Xiao Xi-Bin, Xie Zhao-Xia
Department of Hematology, Xiangya Hospital, Central South University, Changsha 410008, China.
Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2006 Apr;14(2):384-7.
To construct a plasmid expressing MDR1 short hairpin RNA (shRNA) mediated by pEGFP-C1/U6 vector, two coding sequences of 19 nucleotides were selected from MDR. Two pairs of oligonucleotides were designed for these two fragments. After annealing the formed double-stranded DNAs were ligated with plasmid pEGFP-C1/U6 (pEGFP-C1 vector with U6 promoter). The plasmids producing MDR1 shRNA were constructed from the inverted motif containing 9 spacers and four Ts. The results showed that the constructed plasmids were named pEGFP-C1/U6/A and pEGFP-C1/U6/B, and the constructs were identified by restriction and sequence analysis, no any base mutation was observed. It is concluded that plasmids of pEGFP-C1/U6/A and pEGFP-C1/U6/B expressing MDR1 shRNA were successfully constructed, providing a highly effective method for reversing the multidrug resistance in clinic.
为构建由pEGFP-C1/U6载体介导表达MDR1短发夹RNA(shRNA)的质粒,从MDR中选择两条19个核苷酸的编码序列。针对这两个片段设计了两对寡核苷酸。退火后形成的双链DNA与质粒pEGFP-C1/U6(带有U6启动子的pEGFP-C1载体)连接。产生MDR1 shRNA的质粒由包含9个间隔区和四个T的反向基序构建而成。结果显示,构建的质粒命名为pEGFP-C1/U6/A和pEGFP-C1/U6/B,通过酶切和序列分析对构建体进行鉴定,未观察到任何碱基突变。结论是成功构建了表达MDR1 shRNA的pEGFP-C1/U6/A和pEGFP-C1/U6/B质粒,为临床逆转多药耐药性提供了一种高效方法。